CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES >

2019 , Vol. 37 >Issue 6: 723 - 726

DOI: https://doi.org/10.12140/j.issn.1000-7423.2019.06.020

SHORT COMMUNICATIONS

Infections of Clostridium difficile, Blastocystis hominis and Cryptosporidium spp. in patients with chronic diarrhea

  • Ya-ling ZHOU ,
  • Liang WU ,
  • Qing YIN ,
  • Yao WU ,
  • Lei HE ,
  • Zhi-qing ZOU ,
  • Xiao-yue DAI ,
  • Wen XIA
Expand
  • 1 The Department of Clinical Laboratory, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China
    2 School of Medicine, Jiangsu University, Zhenjiang 212013, China

Received date: 2019-06-06

  Online published: 2019-12-31

Supported by

Supported by 2017 Science and Technology Innovation Fund of Zhenjiang City(No. SH2017024), 2018 Preventive Medicine Research Project of Jiangsu Province(No. Y2018108), Basic Platform Project of the Ministry of Science and Technology of China(No. platform-TDRC-22)

Fold

Abstract

Ninety-six stool samples were collected from patients with chronic diarrhea at affiliated hospital of Jiangsu University (inpatients and outpatients) in 2018. Each stool sample was smeared for microscopic examination. At the same time fecal DNA was extracted. The genes for 16S rDNA, toxin A (tcdA), toxin B (tcdB), binary toxin (cdtA and cdtB) of Clostridium difficile were detected by multiplex PCR. The SSU rRNA gene of Blastocystis hominis was detected by conventional PCR and the SSU rRNA gene of Cryptosporidium spp. was detected by nest-PCR. C. difficile 16S rDNA was detected in 64 out of 96 patients with chronic diarrhea with a positive rate of 66.7%. C. difficile TcdA gene was detected in 24 cases and tcdB gene in 18 cases of all C. difficile positive samples. There was no sample with only tcdB. No cdtA and cdtB genes were detected in any C. difficile positive sample. The rate of toxigenic strain was 37.5%. Microscopic examination detected 16 B. hominis infected samples with detection rate of 16.7%. PCR results showed that 21 samples B. hominis SSU rRNA gene was amplified in 96 stool samples with a detection rate of 21.9%. All microscopic positive samples were positive in PCR detection. No mixed infection of C. difficile and B. hominis was detected. The Cryptosporidium spp. SSU rRNA gene was not detected in all stool samples. The results showed that C. difficile and B. hominis were the main organisms detected in patients with chronic diarrhea in Nanjing area.

Key words： Chronic diarrhea; Clostridium difficile; Blastocystis hominis; Cryptosporidium spp.

Cite this article

Ya-ling ZHOU , Liang WU , Qing YIN , Yao WU , Lei HE , Zhi-qing ZOU , Xiao-yue DAI , Wen XIA . Infections of Clostridium difficile, Blastocystis hominis and Cryptosporidium spp. in patients with chronic diarrhea[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2019 , 37(6) : 723 -726 . DOI: 10.12140/j.issn.1000-7423.2019.06.020

References

[1] 姚静, 王文婷, 宁岩. 感染性腹泻流行现状分析及护理管理对策研究[J]. 中国卫生产业, 2015, 20(19): 119-121.
[2] Farthing M, Salam MA, Lindberg G, et al. Acute diarrhea in adults and children: a global perspective[J]. J Clin Gastroenterol, 2013, 1(47): 12-20.
[3] 徐少毅, 冯雪君, 陆晓凤, 等. 108例艰难梭菌相关性腹泻患者的临床诊治分析[J]. 中华医院感染学杂志, 11(29): 1614-1618.
[4] 滕雪娇, 储言红, 翟铖铖, 等. 云南腾冲人类免疫缺陷病毒携带者人芽囊原虫感染的流行病学特征及影响因素分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(2): 129-134.
[5] 滕雪娇, 陈家旭, 田利光. HIV/AIDS患者合并肠道原虫感染状况[J]. 中国寄生虫学与寄生虫病杂志, 2017, 6(35): 607-614.
[6] 徐宁, 尹建海, 沈玉娟, 等. 隐孢子虫和蓝氏贾第鞭毛虫分子流行病学研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(6): 661-665.
[7] Kelly CP, LaMont JT. Clostridium difficile: more difficult than ever[J]. N Engl J Med, 2008, 359(18): 1932-1940.
[8] Musgrave CR, Bookstaver PB, Sutton SS, et al. Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection[J]. Int J Infect Dis, 2011, 15(7): e438-e448.
[9] Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections[J]. N Engl J Med, 2014, 370(13): 1198-1208.
[10] 宋鹏, 李浩, 郭俭, 等. 2014-2017年上海市临床医院送检样品寄生虫检测结果分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(5): 489-494.
[11] Sandhu SK, Priest JW, Lammie PJ, et al. The natural history of antibody responses to Cryptosporidium parasites in men at high risk of HIV infection[J]. J Infect Dis, 2006, 194(10): 1428-1437.
[12] Fletcher SM, Stark D, Harkness J, et al. Enteric Protozoa in the developed world: a public health perspective[J]. Clin Microbiol Rev, 2012, 25(3): 420-449.
[13] Nsagha DS, Njunda AL, Assob NJC, et al. Intestinal parasitic infections in relation to CD4(+)T cell counts and diarrhea in HIV/AIDS patients with or without antiretroviral therapy in Cameroon[J]. BMC Infect Dis, 2016, 16: 9.
[14] Wanyiri JW, Kanyi H, Maina S, et al. Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology,molecular characterization and antibody responses[J]. Am JTrop Med Hyg, 2014, 91(2): 319-328.
[15] Persson S, Torpdahl M, Olsen KE.New multiplex PCR method for the detection of Clostridium difficile toxin A(tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection[J]. Clin Microbiol Infect, 2008, 14(11): 1057-1064.
[16] Scicluna SM, Tawari B, Clark CG, et al. DNA barcoding of Blastocystis[J]. Protist, 2006, 157(1): 77-85.
[17] Xiao L, Singh A, Limor J, et al. Molecular characterization of Cryptosporidium oocysts in samples of raw surface water and wastewater[J]. Appl Environ Microbiol, 2001, 67(3):1097-1101.
[18] 廖亚龙, 侯铁英, 邵裕燊, 等. 艰难梭菌感染临床特征与危险因素分析[J]. 中华医院感染学杂志, 2016, 26(21): 4837-4840.
[19] 朱慧慧, 周长海, 陈颖丹, 等. 全国人体重点寄生虫病现状调查SWOT分析[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(5): 377-381.
[20] 杨佩才, 张洪英, 周玮, 等. 2015-2016年南京市隐孢子虫抽样调查报告[J]. 中国血吸虫病防治杂志, 2017, 29(6): 752-755.
[21] 谢和宾, 曾鸿, 尹柯, 等. 我国住院腹泻患者艰难梭菌感染率的荟萃分析[J]. 中华医院感染学杂志, 2017, 27(5): 961-964.
[22] 徐亚青, 邓敏. 难辨梭状芽孢杆菌医院感染的流行病学特征及感染控制现状分析[J]. 中华医院感染学杂志, 2013, 23(20): 5073-5075.
[23] 刘元元, 刘文恩, 简子娟, 等. 住院腹泻患者艰难梭菌检测与分析[J]. 中国感染控制杂志, 2012, 11(4): 293-296.
[24] 胡缨, 李艳文, 刘晓泉, 等. 慢性病患者合并人芽囊原虫感染的情况调查[J]. 中国卫生检验杂志, 2017, 27(19): 2558-2560
[25] Carreno RA, Pokorny NJ, Lee H, et al. Phenotypic characterization of Cryptosporidium species and isolates[J]. Microbio Biotechn, 2001, 26(3): 95-106.
Options
Outlines

/

〈 〉